Company intelligence / Profile preview
Koçak Farma
Istanbul, Istanbul, Turkeykocakfarma.com ↗
- Ownership
- Private
- Employees
- ~1850
- Development stage
- Commercial
01
Overview
Koçak Farma has over 600 products on the market with a strong focus on oncology—producing one in every two cancer drugs sold in Turkey. The company was the first to launch biosimilars such as enoxaparin sodium and insulin analogues in Turkey. It holds EU GMP certification and exports both APIs and finished products globally. Its R&D center develops monoclonal antibodies and vaccines alongside conventional small molecules[1][2][6].
- Therapeutic areas
- CardiovascularMen's HealthMetabolic DisordersRheumatologyWomen's HealthOncologyInfectious Diseases
- Modalities
- Small moleculeMonoclonal antibodyBiosimilarVaccineProtein
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborations with leading European companies for R&D and production[1]Contract manufacturing for local/international pharma companies
Beyond the preview
Go deeper on Koçak Farma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Koçak Farma.